Biostar Pharmaceuticals, Inc. (BSPM)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
Biostar Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2011 - 2007 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2011 - 2007 |
| Market Capitalization | 0 | 8 | 6 | 18 | 26 | 10 | Upgrade
|
| Market Cap Growth | -100.00% | 24.45% | -65.71% | -29.15% | 155.73% | -42.84% | Upgrade
|
| Enterprise Value | - | 9 | 9 | 14 | 20 | -2 | Upgrade
|
| Last Close Price | 0.00 | 2.93 | 2.81 | 8.19 | 14.49 | 7.00 | Upgrade
|
| PE Ratio | 0.00 | - | - | 3.74 | 31.59 | - | Upgrade
|
| PS Ratio | 0.00 | 3.24 | 0.23 | 0.30 | 0.49 | 0.20 | Upgrade
|
| PB Ratio | - | 0.21 | 0.14 | 0.25 | 0.41 | 0.17 | Upgrade
|
| P/TBV Ratio | - | 0.25 | 0.17 | 0.31 | 0.56 | 0.21 | Upgrade
|
| P/FCF Ratio | - | 1.57 | 1.07 | 41.02 | 3.22 | - | Upgrade
|
| P/OCF Ratio | - | 1.57 | 1.06 | 5.47 | 2.87 | - | Upgrade
|
| EV/Sales Ratio | - | 3.98 | 0.33 | 0.22 | 0.38 | - | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 3.09 | 5.63 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | 10.39 | 26.58 | - | Upgrade
|
| EV/FCF Ratio | - | 1.93 | 1.53 | 30.72 | 2.51 | - | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.06 | 0.06 | 0.04 | - | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 0.62 | - | - | 0.70 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.28 | 0.47 | 0.48 | 7.01 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.06 | 0.06 | 0.06 | 0.02 | 0.00 | 0.08 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.53 | -0.89 | -0.32 | 0.32 | -0.02 | -0.44 | Upgrade
|
| Net Debt / FCF Ratio | 0.24 | 0.44 | 0.47 | 3.19 | -0.01 | -1.27 | Upgrade
|
| Asset Turnover | 0.01 | 0.05 | 0.41 | 0.83 | 0.76 | 0.64 | Upgrade
|
| Inventory Turnover | 1.16 | 7.32 | 35.27 | 41.40 | 32.25 | 17.53 | Upgrade
|
| Quick Ratio | 0.16 | 1.28 | 2.25 | 3.23 | 4.57 | 2.20 | Upgrade
|
| Current Ratio | 0.19 | 1.31 | 2.28 | 4.90 | 7.51 | 3.30 | Upgrade
|
| Return on Equity (ROE) | 2.66% | -14.04% | -43.07% | 7.18% | 1.34% | -29.81% | Upgrade
|
| Return on Assets (ROA) | 4.25% | -4.75% | -10.25% | 1.10% | 0.68% | -9.88% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.92% | -8.29% | -18.01% | 1.87% | 0.36% | -19.81% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.70% | -9.70% | -24.60% | 1.80% | 1.20% | -21.00% | Upgrade
|
| Earnings Yield | 31145100.00% | -73.75% | -404.45% | 26.77% | 3.17% | -200.10% | Upgrade
|
| FCF Yield | - | 63.58% | 93.70% | 2.44% | 31.02% | -36.19% | Upgrade
|
| Buyback Yield / Dilution | -18.37% | -3.91% | -6.74% | -25.96% | -20.27% | -2.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.